Norman David Eansor's Net Worth

$28.1 Million

Estimate Recalculated Nov 7, 2024 11:32AM EST

Who is Norman David Eansor?

Norman David Eansor has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include TECHNE CORP /MN/, CAMBREX CORP, and Marker Therapeutics, Inc..

SEC CIK

Norman David Eansor's CIK is 0001270905

Past Insider Trading and Trends

2020 was Norman David Eansor's most active year for acquiring shares with 11 total transactions. Norman David Eansor's most active month to acquire stocks was the month of July. 2021 was Norman David Eansor's most active year for disposing of shares, totalling 25 transactions. Norman David Eansor's most active month to dispose stocks was the month of April. 2021 saw Norman David Eansor paying a total of $7,256,463.87 for 106,114 shares, this is the most they've acquired in one year. In 2021 Norman David Eansor cashed out on 140,342 shares for a total of $27,480,281.69, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TECHNE CORP /MN/ (TECH) Snapshot price: $71.49

President-Protein Sciences

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+60.62%
799
$314.52
-$10,192,045.04
2.12K
Nov 12 - Nov 16
Form 4
-53.85%
-1.54K
$503.07
-$773,727.66
1.32K
Aug 31
Form 4
+116.69%
1.54K
$481.82
-$481,338.18
2.86K
Aug 6 - Aug 8
Form 4
—
0
$243.64
-$9,026,694.44
1.32K
Feb 5
Form 4
∞
1.32K
$265.76
-$227,490.56
1.32K
Aug 9
Form 4
—
0
—
—
0
Aug 5
Form 4
—
0
$184.97
-$1,737,153.16
0
May 28 - May 29
Form 4
—
0
$183.63
-$3,975,963.49
0
May 21 - May 22
Form 4
-100.00%
-1.39K
$198.68
-$275,569.16
0
Mar 4
Form 4
∞
1.39K
$197.57
-$177,813.00
1.39K
Aug 19
Form 4
—
0
—
—
0
Aug 7
Form 4
-100.00%
-3.12K
$215.00
-$670,155.00
0
Scheduled
Jun 12
Form 4
+37.56%
851
$180.14
-$62,688.72
3.12K
Aug 7 - Aug 8
Form 4
-33.39%
-1.14K
$145.19
-$164,931.75
2.27K
May 4
Form 4
—
0
—
—
0
Oct 26
Form 4
-13.57%
-534.00
$117.50
-$62,745.00
3.4K
Jul 1
Form 4
—
0
—
—
0
Aug 18
Form 4
-11.93%
-533.00
$112.24
-$59,823.92
3.94K
Jul 1
Form 4/A
—
0
—
—
0
Aug 7
Form 4
—
0
—
—
0
Aug 7
Form 4
—
0
—
—
0
Aug 7
Form 4
∞
1.14K
$96.54
-$51,262.74
1.14K
Jul 2
Form 4
—
0
—
—
0
Aug 12
Form 4
—
0
—
—
0
Jul 2
Form 3
—
0
—
—
0
No matching records found

CAMBREX CORP No price found

President Bioproducts

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.60%
-1.44K
$20.49
-$29,485.11
6.3K
Jan 6
Form 4
—
0
—
—
0
Jul 25
Form 4
+88.71%
4.22K
—
—
8.98K
Dec 31 - Jan 27
Form 4
—
0
—
—
0
Aug 23
Form 4
-65.14%
-7.30K
$25.92
-$189,202.00
3.91K
Mar 17
Form 4
+16.68%
1.22K
—
—
8.52K
Jan 22
Form 4
-30.48%
-3.20K
$25.30
-$80,960.00
7.3K
Dec 23
Form 3
—
0
—
—
0
No matching records found

Marker Therapeutics, Inc. (MRKR) Snapshot price: $3.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+588.30%
14.28K
$17.50
$249,987.50
16.71K
Mar 16 - Jun 6
Form 4
—
0
—
—
0
May 24
Form 4
+52.13%
12.66K
—
—
36.94K
Jun 8
Form 4
∞
7.26K
—
—
7.26K
May 9
Form 4
—
0
—
—
0
Oct 17
Form 3
—
0
—
—
0
No matching records found